{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:15:35Z","timestamp":1782234935269,"version":"3.54.5"},"reference-count":36,"publisher":"Informa UK Limited","issue":"17","funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2025,9,2]]},"DOI":"10.1080\/17576180.2025.2554563","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T07:57:42Z","timestamp":1756972662000},"page":"1083-1095","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Overcoming bioanalytical challenges during the development of risdiplam for the treatment of spinal muscular atrophy"],"prefix":"10.1080","volume":"17","author":[{"given":"Katja","family":"Heinig","sequence":"first","affiliation":[{"name":"F. Hoffmann-La Roche Ltd","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Dzygiel","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ferrari","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-014-0314-x"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00741"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.447"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13786"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2009965"},{"key":"e_1_3_7_8_1","unstructured":"Food and Drug Administration. Fda approves oral treatment for spinal muscular atrophy [Internet]. 2020. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-oral-treatment-spinal-muscular-atrophy"},{"key":"e_1_3_7_9_1","unstructured":"European Medicines Agency. Evrysdi: summary of product characteristics [Internet]. 2021. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/evrysdi-epar-product-information_en.pdf"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.121.000563"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51239"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2017-0175"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2020.122388"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2020-0237"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2015.237"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.70173"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1787\/9789264078536-en"},{"key":"e_1_3_7_18_1","unstructured":"European Medicines Agency reflection paper for laboratories that perform the analysis or evaluation of clinical trial samples EMA\/INS\/GCP\/532137\/2010. 2012. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/reflection-paper-laboratories-perform-analysis-or-evaluation-clinical-trial-samples_en.pdf"},{"key":"e_1_3_7_19_1","unstructured":"Fda bioanalytical method validation guidance for industry [Internet]. 2001. Available from: https:\/\/www.moh.gov.bw\/Publications\/drug_regulation\/Bioanalytical%20Method%20Validation%20FDA%202001.pdf"},{"key":"e_1_3_7_20_1","unstructured":"Fda bioanalytical method validation guidance for industry [Internet]. 2018. Available from: https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm070107.pdf"},{"key":"e_1_3_7_21_1","unstructured":"European Medicines Agency guideline on bioanalytical method validation. [Internet]. 2011. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf"},{"key":"e_1_3_7_22_1","volume-title":"Guidance for quantitative bioanalytical methods validation, pharmacopoeia of the People\u2019s Republic of China","author":"State Commission of Chinese Pharmacopoeia","year":"2015","unstructured":"State Commission of Chinese Pharmacopoeia. Guidance for quantitative bioanalytical methods validation, pharmacopoeia of the People\u2019s Republic of China. 2015. Beijing (China): Medical Science and Technology Press."},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2018.10.001"},{"key":"e_1_3_7_24_1","volume-title":"AAPS Annual Meeting and Exposition, Poster W4120","author":"Heinig K","year":"2017","unstructured":"Heinig K, Wirz T, Bucheli F, et al. Lifecycle of bioanalytical methods for the determination of RG7800, a survival motor neuron 2 splicing modifier. In: AAPS Annual Meeting and Exposition, Poster W4120; San Diego; 2017."},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.10.114"},{"key":"e_1_3_7_26_1","unstructured":"Swissmedic. Swiss Agency for Therapeutic Products. Swiss public assessment report evrysdi [Internet]. 2021. Available from: https:\/\/www.swissmedic.ch\/dam\/swissmedic\/de\/dokumente\/zulassung\/swisspar\/67251-evrysdi-01-swisspar-20210617.pdf.download.pdf\/SwissPAR_Evrysdi.pdf"},{"key":"e_1_3_7_27_1","unstructured":"Fda guidance for industry safety testing of drug metabolites. Available from: https:\/\/www.fda.gov\/media\/72279\/download[Internet]2020"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2384"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.1897"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234502"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/306179"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.07.013"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.1572"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.14.290"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.14.34"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-025-01033-w"},{"key":"e_1_3_7_37_1","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH): iCH guideline M10 on bioanalytical method validation and study sample analysis. Available from: https:\/\/www.inotiv.com\/hubfs\/ICH-Harmonized-Guideline-for-Bioanalytical-Method-Validation-and-Study-Sample-Analysis-M10.pdf[Internet]2022"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics2040364"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17576180.2025.2554563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T11:44:21Z","timestamp":1760787861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17576180.2025.2554563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":36,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025,9,2]]}},"alternative-id":["10.1080\/17576180.2025.2554563"],"URL":"https:\/\/doi.org\/10.1080\/17576180.2025.2554563","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-03-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}